| Literature DB >> 27643873 |
Rachel J J Elands1, Colinda C J M Simons1, Martien van Dongen1, Leo J Schouten1, Bas A J Verhage1, Piet A van den Brandt1, Matty P Weijenberg1.
Abstract
BACKGROUND: In animal models, long-term moderate energy restriction (ER) is reported to decelerate carcinogenesis, whereas the effect of severe ER is inconsistent. The impact of early-life ER on cancer risk has never been reviewed systematically and quantitatively based on observational studies in humans.Entities:
Mesh:
Year: 2016 PMID: 27643873 PMCID: PMC5028056 DOI: 10.1371/journal.pone.0158003
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1PRISMA flow diagram showing a breakdown of the study selection.
Characteristics of included cohort and case-control studies.
| Studies in chronological order of publication | Design | Country | Historical event | Intervention versus nonintervention cohort/arm (ascertainment of intervention) | Follow-up (years) | Completeness of follow-up | Cases (controls) | N cohort (subcohort) | Adjustments | End-points |
|---|---|---|---|---|---|---|---|---|---|---|
| Dirx et al., 1999 [ | Case- cohort | The Netherlands | Dutch Hunger Winter | Lived in Western city vs. non-Western area (questionnaire) | 6.3 | >96% | 1009 | 62,573 (1716) | Breast cancer risk | |
| Dirx et al., 2001 [ | Case- cohort | The Netherlands | Dutch Hunger Winter | Lived in Western city vs. non-Western area (questionnaire) | 7.3 | >96% | 903 | 58,279 (1630) | Prostate cancer risk | |
| Robsahm et al., 2002 [ | Cohort | Norway | World War 2 | Non-food versus food producing areas (registry) | 28 | - | 7311 | 597,906 | Breast cancer risk | |
| Elias et al., 2004 [ | Case-cohort | The Netherlands | Dutch Hunger Winter | Hunger vs. no hunger (questionnaire) | 15.3 (median) | 95% | 585 | 15,396 (2352) | Breast cancer risk | |
| Fentiman et al., 2007 [ | Cohort | England | Occupation of Guernsey | Stayed vs. evacuated (questionarre) | 15–20 | - | 97 | 2,377 | Breast cancer risk | |
| Koupil et al., 2009 [ | Cohort | Russia | Siege of Leningrad | Lived in Leningrad vs. outside Leningrad (registry) | 23–30 | ~95% | 792 | 5330 | Breast-, prostate-, stomach-, colorectal-, respiratory-, other cancers and all-site cancer mortality | |
| Keinan-Boker et al., 2009 [ | Cohort | Israël | Holocaust | Immigrated after the war vs. before the war (registry) | 21 | ~93% | 69,297 | 315,544 | - | Breast-, prostate-, stomach-, colorectal-, lung and bronchial-, other cancers and all-site cancer risk |
| Hughes et al., 2010 [ | Case- cohort | The Netherlands | Dutch Hunger Winter | Lived in Western city vs. non-Western area (questionnaire) | 16.3 | >96% | 2971 | 120,852 (3981) | Colorectal cancer risk | |
| Heinen et al., 2011 [ | Case- cohort | The Netherlands | Dutch Hunger Winter | Lived in Western city vs. non-Western area (questionnaire) | 13.3 | >96% | 446 | 120,852 (4774) | Pancreatic cancer risk | |
| Schouten et al., 2011 [ | Case- cohort | The Netherlands | Dutch Hunger Winter | Lived in Western city vs. non-Western area (questionnaire) | 16.3 | >96% | 394 | 62,573 (2589) | Ovarian cancer risk | |
| Li et al., 2012 [ | Cohort | China | Chinese Famine during Great Leap Forward | Born between 1930–1964 vs. born between 1965–1999 (registry) | 4 | - | 162 | - | Stomach cancer mortality | |
| Vin-Raviv et al., 2012 [ | Case-control | Israël | Holocaust | Hunger vs. no hunger (structured interview) | - | - | 65 (200) | - | Breast cancer risk |
a Anthropometric variables (body mass index and height)
b reproductive variables (parity, age at first birth, age at menopause, hormone replacement therapy (never, ever), oral contraceptive use (ever, never), hysterectomy (yes, no))
c smoking or alcohol consumption
d socio-economic variables (education and economic status)
e genetic factors (family history or genetic mutation tests) or
f variables that indicate baseline energy consumption or energy expenditure (physical activity and energy intake)
Fig 2Forest plot showing a meta-analysis of cohorts on the association between transient early-life energy restriction and the relative risk and mortality of breast cancer, using the relative risk estimate as summary statistic.
Note: Subgroup analyses were performed for childhood (in utero-10 years old) and adolescent (10–20 years old) exposure to ER in relation to breast cancer risk. If individual studies provided risk ratio estimates for different birth cohorts, these were pooled and the pooled estimate was taken along in the meta-analysis. Abbreviations: CI, confidence interval; BC, breast cancer.
Fig 3Forest plot showing a meta-analysis of cohorts on the association between transient energy restriction during (pre)adolescence and the relative risk and mortality of prostate cancer.
Note: If individual studies provided risk ratio estimates for different birth cohorts, these were pooled and the pooled estimate was taken along in the meta-analysis. Abbreviations: CI, confidence interval; PC, prostate cancer.
Fig 4Forest plot showing a meta-analysis of cohorts on the association between transient energy restriction during (pre)adolescence and the relative risk and mortality at sites other than prostate cancer risk in males and breast cancer risk in females.
Note: If individual studies provided risk ratio estimates for different birth cohorts, these were pooled and the pooled estimate was taken along in the meta-analysis. Abbreviations: CI, confidence interval; CRC, colorectal cancer; SC, stomach cancer; PaC, pancreatic cancer; LC, lung cancer; OC, ovarian cancer.
Meta-regression for exposure to early-life energy restriction and all type cancer risk/mortality including moderators.
| Endpoint | Mixed-effects model unless otherwise specified | Beta intercept | 95% CI | Beta | 95% CI | I2 | R2 | Test for heterogeneity | Test for residual heterogeneity | Test of moderators |
|---|---|---|---|---|---|---|---|---|---|---|
| All cancers women | RE model | 0.20 | (0.07, 0.34) | 57.41% | 0.002 | |||||
| RR ~ severity of exposure | 0.41 | (0.06, 0.76) | -0.03 | (-0.08, 0.02) | 48.06% | 37.40% | 0.01 | 0.20 | ||
| RR ~ duration of exposure | 0.05 | (-0.07, 0.17) | <0.01 | (0, 0.01) | 0.02% | 99.99% | 0.15 | <0.001 | ||
| RR ~ severity of exposure + | 0.10 | (-0.31, 0.51) | -0.01 | (-0.06, 0.04) | 0.00% | 100.00% | 0.11 | <0.001 | ||
| duration of exposure | <0.01 | (0, <0.01) | ||||||||
| All cancers men | RE model | 0.26 | (0.06, 0.46) | 84.42% | <0.001 | |||||
| RR ~ severity of exposure | - | - | 83.01% | 0.00% | <0.001 | 0.54 | ||||
| RR ~ duration of exposure | -0.01 | (-0.30, 0.33) | 0.01 | (>-0.01, 0.01) | 77.73% | 29.26% | <0.001 | 0.07 | ||
| RR ~ severity of exposure + | 0.05 | (-0.63, 0.73) | <0.01 | (>-0.01, <0.01) | 73.92% | 36.64% | <0.001 | 0.08 | ||
| duration of exposure | 0.01 | (0, 0.01) |
Note: The unit increases in severity of exposure and duration of exposure were 100 kilocalories per day and months, respectively; severity and duration of exposure were inversely correlated in women and men (r = -0.36 and -0.12, respectively; p = 0.24 and 0.76, respectively). Abbreviations: CI, confidence interval; RE model, random-effects model; RR, relative risk.
* Estimates are not shown, because the test of moderators was not statistically significant
Fig 5An overview of some of the contextual aspects of energy restriction that might modulate the association of early-life energy restriction with cancer risk.
Note: The estimated caloric intake (in units of 100 kcal/day) was based on the mid-point caloric intake reported in the publications and was plotted against the reported relative risk ratios from the individual studies separately for women (panel A) and men (panel C). The estimated duration of ER (in months) was plotted against the reported relative risk ratios from the individual studies separately for women (panel B) and men (panel D). In women, the data points indicated in red represent studies reporting on breast cancer risk or mortality; the data points indicated in blue represent studies reporting on colorectal cancer risk or mortality; the data points indicated in green represent studies reporting on stomach cancer risk or mortality; the data points indicated in grey represent studies reporting on lung cancer risk or mortality; and the data points indicated in yellow represent a report on ovarian cancer risk. In men, the data points indicated in red represent studies reporting on prostate cancer risk or mortality; the data points indicated in blue represent studies reporting on colorectal cancer risk or mortality; the data points indicated in green represent studies reporting on stomach cancer risk or mortality; and the data points indicated in grey represent studies reporting on lung cancer risk or mortality. The dashed lines indicate the confidence intervals of the meta-regression line.